flecha

Service

flecha
FLYLIFE
FLYLIFE manufactures recombinant proteins at industrial scale, using insect larvae as biofactories. We offer customized manufacturing contracts (CMO) for pharmaceutical, biotechnology, veterinary, and diagnostic companies
Large scale recombinant protein expression in a high-versatile system. The system is based on caterpillars as mini-disposable biofactories using a Baculovirus Expression Vector System (BEVS) technology. Economically rational approach to be prepared to halt pandemic or bioalarms at a local basis. A multiproduct FLYLIFE-based manufacturing plant shows:

- Low capital investment and low fixed costs
- Minimum space demand
- High-versatile protein expression
- High yield
- High scale-up speed. Delivering first batch in less than 12 weeks
- Biological safety. Devoid compounds of animal origin

Designed to fully compliance with EMEA and FDA cGMP guidelines. For human and animal applications.
 
Link More information
 
Tags   recombinant   therapeutic   protein   cmo   cgmp   biosimilars
Permalink  
Delicious  Technorati  Facebook  Twitter  Meneame 
Search
linea
Google Custom Search
BioRegión Collaborative Area
BioRegión Collaborative Area
RSS
linea
RSS RSS Andalucía BioRegión
User Acces
linea
Email:
Password:

Register

Forgot your password?

Companies/centers Acces
line
Email:
Password:

Register your company

Forgot your password?

Tag cloud
line
View more tags
BioRegión Collaborative Area